Home     Job Openings     Directions     Contact Us
Fairbanks Donate Now Find us on Facebook Annual Report 09-10
Getting Help Referral Sources Hope Academy Stay Connected Education Contributions About Us
 

Substance- Impacted Children

In the Era of "No Child Left Behind"

Bulletin No. 3 -- August 2004

Benchwork: The First Phase In Developing "Best Practices"


Sigurd H. Zielke, Clinical Specialist


Benchwork is the term that medical-clinical researchers use to describe the earliest phase of study in the process of developing medications, devises or practices to be used for clinical interventions. Through the study of cell cultures, isolated tissues, and animal models, researchers demonstrate which materials or interventive methods are structurally sound and show potential efficacy for treating a targeted condition or disease. Thus, the goal of the benchwork phase of medical research is to identify and develop compounds/devices and/or practices of promise.

Before a compound/device or practice of promise can be applied in clinical practice, it must undergo various levels of field-trials, i.e., trials in larger populations to test for its effectiveness, safety and reliability. If the identified compound/device or practice is found to be effective, safe and reliable, it is then tried against existing medications or procedures; and then, if found to perform at superior levels with good reliability, a best practice status is granted.

The Substance-Impacted Children and the School project has adopted a similar clinical benchwork field-trial approach to accomplish its mission of providing educators with the best strategies and tools to address the behavior and learning problems of students negatively impacted by substances. This very purposeful and rigorous empirical approach was adopted to mirror the same quality processes, standards and assurances that Americans have come to expect in the creation of the medical interventions they receive.

The faculty of the SI-Children and the School project is presently engaged in the benchwork phase. This involves developing strategies, methods and tools for helping substance-impacted and similarly at-risk children (students who exhibit similar problems and risk factors without parental substance abuse) do well at school while enhancing the learning environment for all students. Equally important as efficacy is the assurance that the interventions developed are educator friendly. With all the pressures that educators are under in this the era of No Child Left Behind, a priority of the project is to develop interventions that support and enhance teacher efficacy, not complicate their daily work.

The benchwork phase of the research began in July of 2004 and runs through May 2005. July and early August of the current year, the project's staff has been focused on clarifying the school problems of SI-children and identifying potential interventive strategies. Findings from the project's inaugural field-based, focus group study of administrators, counselors, and student support staff from ten area elementary schools (Substance-Impacted Children: A Study from the School Perspective, Zielke, 2003) are being compared and contrasted with findings identified through literature reviews of pertinent research. As these two lines of study are converged, clusters of salient problems are noted and translated into structural maps and operational terms. Potential interventive strategies will then being identified.

The action research portion of the benchwork (described in this bulletin under Fairbanks & CELL Conduct "Action Research" To Develop Interventions To Assist SI-Children) begins in late August of 2004 and runs through April 2005. It will culminate in a series of reports to be published in the summer and fall of 2005.


Substance-Impacted Children & the School Project
A Fairbanks and University of Indianapolis-CELL Collaboration

Project Faculty
Dr. Theresa Akey, Research Fellow, CELL
Charlotte Pontius, Director of Program Development, Fairbanks
Stephanie Stscherban, Project Coordinator, CELL
Susan M. Zapach, Special Education Fellow, CELL
Debra Zielke, Research Associate, Fairbanks
Dr. Sigurd H. Zielke, Clinical Specialist, Fairbanks


Home
United Way of Central Indiana Fairbanks Alcohol and Drug Treatment
8102 Clearvista Parkway, Indianapolis, IN 46256-4698
For more information call 317-849-8222, 1-800-225-4673 or Email. Privacy Information